During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

Any investor hoping to reap the rewards by holding marijuana companies must be a shiny-eyed optimist at this point. Weed ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.iXkfgCgn.js ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage ...

However, we see little synergies across Tilray's portfolio of cannabis, alcoholic beverages, and wellness products as the markets, distribution systems, and regulatory systems are vastly different.

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Additionally, it reinforces Tilray’s commitment to deliver on Europe’s growing demand for premium medical cannabis products. Denise Faltischek, Chief Strategy Officer and Head of International ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Tilray (TLRY – Research Report) today and set a price target of $2.00. The ...

One of the top cannabis stocks in the industry is Tilray ... with respect to expansion or offering too many types of products. While Tilray has been eager to become a top craft beer company ...